HLB Life Science Co., Ltd. (KOSDAQ:067630)
3,955.00
-50.00 (-1.25%)
At close: Feb 6, 2026
-62.04% (1Y)
| Market Cap | 481.91B -62.9% |
| Revenue (ttm) | 114.33B +147.1% |
| Net Income | -178.33B |
| EPS | -1,434.56 |
| Shares Out | 121.85M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 405,227 |
| Average Volume | 756,421 |
| Open | 3,960.00 |
| Previous Close | 4,005.00 |
| Day's Range | 3,845.00 - 3,990.00 |
| 52-Week Range | 3,105.00 - 11,940.00 |
| Beta | -0.06 |
| RSI | 42.34 |
| Earnings Date | Mar 19, 2026 |